Charles M. Winter
CIK: 0001960264
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JANX
Janux Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Winter Charles M.
Winter Charles M. (SEC CIK 0001960264) files insider reports with the SEC as Chief Technical Officer of Janux Therapeutics, Inc. (JANX).
Signal8 holds 3 ownership filings by Winter Charles M. (1 Form 3, 2 Form 4), filed between Jan 3, 2025 and Jan 2, 2026. Those filings report 3 transactions, from Jan 2, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Winter Charles M.'s filings is in SAN DIEGO, CA.
Recent filings by Winter Charles M.
Other insiders filing for Janux Therapeutics, Inc. (JANX)
- Campbell David Alan, President and CEO
- RA CAPITAL MANAGEMENT, L.P., Director
- Simson Jake, Director
- Kung Winston, Director
- Hernday Natasha, Director
- DOBMEIER ERIC, Director